2008
181. Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice.
Vasiljeva O, Korovin M, Gajda M, Brodoefel H, Bojic L, Krüger A, Schurigt U, Sevenich L, Turk B, Peters C, Reinheckel T
Oncogene. 2008 Jul 10.
186. Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma.
Zhong JL, Poghosyan Z, Pennington CJ, Scott X, Handsley MM, Warn A, Gavrilovic J, Honert K, Krüger A, Span PN, Sweep FC, Edwards DR
Mol Cancer Res. 2008 Mar .
187. Distinct functionality of tumor cell-derived gelatinases during formation of liver metastases.
Gerg M, Kopitz C, Schaten S, Tschukes A, Kahlert C, Stangl M, von Weyhern CW, Brücher BL, Edwards DR, Brand K, Krüger A
Mol Cancer Res. 2008 Mar .
188. Efficient and stable gene transfer of growth factors into chondrogenic cells and primary articular chondrocytes using a VSV.G pseudotyped retroviral vector.
Vogt S, Ueblacker P, Geis C, Wagner B, Wexel G, Tischer T, Krüger A, Plank C, Anton M, Martinek V, Imhoff AB, Gansbacher B
Biomaterials. 2008 Mar .
190. The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies.
Gast D, Riedle S, Issa Y, Pfeifer M, Beckhove P, Sanderson MP, Arlt M, Moldenhauer G, Fogel M, Krüger A, Altevogt P
Oncogene. 2008 Feb 21.
